UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease

Orphanet journal of rare diseases, 2020-09, Vol.15 (1), p.256-256, Article 256

2020

Volltextzugriff (PDF)

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome

Thrombosis research, 2021-12, Vol.208, p.226-229

2021

Volltextzugriff (PDF)

Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease

Blood cells, molecules, & diseases, 2014-12, Vol.53 (4), p.171-175

2014

Volltextzugriff (PDF)

RESULTS OF PHASE II STUDY OF COMBINED IMMUNOTHERAPY WITH RITUXIMAB PLUS LYMPHOKINE‐ACTIVATED KILLER CELLS AS MAINTENANCE IN FOLLICULAR LYMPHOMA PATIENTS

Hematological oncology, 2019-06, Vol.37 (S2), p.509-510

2019

Volltextzugriff (PDF)

Detecting Early Relapse in Multiple Myeloma (MM) After ASCT: Usefulness of Immuneassays

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e104-e105

2015

Volltextzugriff (PDF)

Myeloma Multiple (MM) IgA subtype. Usefulness of heavy/light IgAk/IgAL quantification for diagnosis and follow-up

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e108-e109

2015

Volltextzugriff (PDF)

Response and Early Relapse Assessment in Multiple Myeloma Treated With Bortezomib: Role of Heavy/Light-Chain Immuneassay

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e101-e102

2015

Volltextzugriff (PDF)

PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN MAINTAINED COMPLETE RESPONSE (CR) AT 30 MONTHS SHOW A SURVIVAL SIMILAR TO A SEX‐ AND AGE‐MATCHED SPANISH GENERAL POPULATION

Hematological oncology, 2017-06, Vol.35 (S2), p.226-227

2017

Volltextzugriff (PDF)

C0541: Incidence of Thrombosis and Thrombosis Recurrence in Patients with High-Risk Anti-Phospholipid Syndrome

Thrombosis research, 2014-05, Vol.133, p.S37-S37

2014

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS AND PROGNOSIS OF ELDERLY (>70 YEARS) FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: MULTICENTRE RETROSPECTIVE ANALYSIS OF THE GELTAMO SPANISH GROUP

Hematological oncology, 2017-06, Vol.35 (S2), p.367-367

2017

Volltextzugriff (PDF)

Novel Management and Screening Approaches for Haematological Complications of Gaucher's Disease

Journal of blood medicine, 2021-01, Vol.12, p.1045-1056

2021

Volltextzugriff (PDF)

P-064 Analysis and validation of the miRNA expression profile in plasma from patients diagnosed with myelodysplastic syndrome

Leukemia research, 2013-05, Vol.37, p.S51-S51

2013

Volltextzugriff (PDF)

Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital

Blood coagulation & fibrinolysis, 2013-03, Vol.24 (2), p.194-198

2013

Volltextzugriff (PDF)

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience

Clinical lymphoma, myeloma and leukemia, 2015-08, Vol.15 (8), p.464

2015

Volltextzugriff (PDF)

Analysis of genotype-phenotype correlation in Gaucher disease type 1 using machine learning techniques

Molecular genetics and metabolism, 2024-02, Vol.141 (2), p.107845, Article 107845

2024

Volltextzugriff (PDF)

Femur Infiltration: A Feature That Predict Bone Complications in Gaucher Disease. Re-Assessing Bone Marrow Involvement through Machine Learning

Blood, 2022-11, Vol.140 (Supplement 1), p.2605-2606

2022

Volltextzugriff (PDF)

PB1975 CHRONIC FATIGUE, ANAEMIA AND MUSCULOSKELETAL AFFECTATION IN GAUCHER DISEASE

HemaSphere, 2019-06, Vol.3 (S1), p.896-897

2019

Volltextzugriff (PDF)

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Blood, 2019-11, Vol.134 (Supplement_1), p.2323-2323

2019

Volltextzugriff (PDF)

Social distancing, home-infusion and oral therapy: Evolving paradigms on Gaucher disease management in Spain during COVID-19 pandemic

Molecular genetics and metabolism, 2021-02, Vol.132 (2), p.S15-S15

2021

Volltextzugriff (PDF)

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Blood, 2020-11, Vol.136 (Supplement 1), p.13-14

2020

Volltextzugriff (PDF)

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Blood, 2021-11, Vol.138 (Supplement 1), p.2599-2599

2021

Volltextzugriff (PDF)

Impact of immunoparesis on Gaucher disease (GD): Results from a network relationship analysis of data at diagnosis of the patients included in the Spanish registry of GD

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S21-S22

2020

Volltextzugriff (PDF)

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

Blood, 2019-11, Vol.134 (Supplement_1), p.492-492

2019

Volltextzugriff (PDF)

Multiple myeloma and Gaucher disease share features of a cytokine profile

Molecular genetics and metabolism, 2015-02, Vol.114 (2), p.S13-S14

2015

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Technology
(27)
Engineering
(20)
Life Sciences & Biomedicine
(12)
Materials Science
(12)
Hematology
(11)
Materials Science, Multidisciplinary
(10)
Mechanics
(10)
Humans
(9)
Parameter Identification
(9)
Engineering, Mechanical
(8)
Engineering, Manufacturing
(7)
Female
(7)
Lymphoma
(7)
Male
(7)
Physical Sciences
(7)
Adult
(6)
Computer Science
(6)
Finite Element Method
(6)
Full-Field Measurements
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study

Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome

Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease

RESULTS OF PHASE II STUDY OF COMBINED IMMUNOTHERAPY WITH RITUXIMAB PLUS LYMPHOKINE‐ACTIVATED KILLER CELLS AS MAINTENANCE IN FOLLICULAR LYMPHOMA PATIENTS

Detecting Early Relapse in Multiple Myeloma (MM) After ASCT: Usefulness of Immuneassays

Myeloma Multiple (MM) IgA subtype. Usefulness of heavy/light IgAk/IgAL quantification for diagnosis and follow-up

Response and Early Relapse Assessment in Multiple Myeloma Treated With Bortezomib: Role of Heavy/Light-Chain Immuneassay

PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN MAINTAINED COMPLETE RESPONSE (CR) AT 30 MONTHS SHOW A SURVIVAL SIMILAR TO A SEX‐ AND AGE‐MATCHED SPANISH GENERAL POPULATION

C0541: Incidence of Thrombosis and Thrombosis Recurrence in Patients with High-Risk Anti-Phospholipid Syndrome

CLINICAL CHARACTERISTICS AND PROGNOSIS OF ELDERLY (>70 YEARS) FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: MULTICENTRE RETROSPECTIVE ANALYSIS OF THE GELTAMO SPANISH GROUP

Novel Management and Screening Approaches for Haematological Complications of Gaucher's Disease

P-064 Analysis and validation of the miRNA expression profile in plasma from patients diagnosed with myelodysplastic syndrome

Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience

Analysis of genotype-phenotype correlation in Gaucher disease type 1 using machine learning techniques

Femur Infiltration: A Feature That Predict Bone Complications in Gaucher Disease. Re-Assessing Bone Marrow Involvement through Machine Learning

PB1975 CHRONIC FATIGUE, ANAEMIA AND MUSCULOSKELETAL AFFECTATION IN GAUCHER DISEASE

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Social distancing, home-infusion and oral therapy: Evolving paradigms on Gaucher disease management in Spain during COVID-19 pandemic

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Impact of immunoparesis on Gaucher disease (GD): Results from a network relationship analysis of data at diagnosis of the patients included in the Spanish registry of GD

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

Multiple myeloma and Gaucher disease share features of a cytokine profile

Suchergebnisse filtern